Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…
Heartflow, Inc. (NASDAQ: HTFL) is delivering the kind of growth story investors usually hope to find before it becomes obvious: rapid revenue expansion, rising gross margins, stronger adoption of a second product line, and a materially higher full-year outlook. In a market…
Amwell (NYSE: AMWL) is trying to do something rare in healthcare technology: become more interesting by becoming less dramatic. After years of telehealth hype, backlash, and normalization, the company’s latest setup suggests a business leaning into discipline, enterprise relevance, and just enough…
Amwell’s setup going into Q2 2026 looks like the kind of telehealth story Wall Street loves to rediscover right after it has ignored it for too long. The company’s August 4 aftermarket earnings report and 5 p.m. ET webcast arrive with a…
Berkshire Hathaway’s giant cash pile, Nvidia’s AI gospel, Amwell’s approaching earnings update, and Washington’s semiconductor investing streak all point to the same market thesis: capital is still chasing the future, but it wants a margin of safety, a chip advantage, and maybe…
Amwell’s (AMWL) leadership page reads like a small thesis on where digital care is trying to go: a mix of clinicians, operators, and technologists built to make virtual healthcare feel less like a workaround and more like a workflow. That matters because…
U.S. equities ended the week of July 17, 2026 on a cautious note, with major indexes consolidating recent gains as investors digested mixed earnings, firmer rate‑hike expectations, and evolving macro risks from weather, energy, and policy.
Equity markets: tech fatigue, earnings rotation…
U.S. stocks pushed higher again on Wednesday, July 15, 2026, as investors leaned into a “lower‑inflation, still‑resilient growth” narrative that is increasingly defining mid‑summer trading. Cooling CPI data, a more patient Federal Reserve outlook, and better‑than‑expected earnings from big banks and AI‑linked…
